There is a large body of literature indicating that aggregated amyloid-β peptide (Aβ) is toxic to neurons and suggesting that this neurotoxicity represents the final common pathway for neuronal degeneration in Alzheimer's disease. Previous studies have shown the outgrowth of a subclone of the rat neuronal cell line PC12 that is resistant to the toxic effect of aggregated Aβ peptide if the parent cell line is grown in the presence of
INTRODUCTION
Amyloid-β peptide (Aβ peptide) is a major constituent of the senile plaques that characterize Alzheimer's disease [1] [2] [3] . Aβ peptide is a heterogeneous peptide derived from proteolytic processing of the β-amyloid precursor protein [3] . The heterogeneous nature of the peptide results from variable posttranslational processing of β-amyloid precursor protein during its biogenesis and\or reinternalization : cleavage by γ-secretase at C-terminal amino acids 39, 40, 42 and 43 ; and cleavage by β-secretase at several different N-terminal residues [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Mutations close to these cleavage sites that result in greater release of Aβ peptide into the extracellular fluid are linked to familial cases of Alzheimer's disease [9] .
A number of studies have also shown that Aβ peptide is toxic to neurons and that its neurotoxic properties may be integral to the neuronal degeneration of Alzheimer's disease [13, 14] . It now appears that the Aβ-(25-35)-peptide region and an aggregated state are necessary for the neurotoxic potential [14] [15] [16] [17] [18] [19] [20] [21] . When soluble, Aβ-(25-35) is non-toxic and can be recognized by a novel cell-surface receptor, the serpin-enzyme complex (SEC) receptor, for endocytosis and clearance [22] . When aggregated, Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) is not recognized by the SEC receptor but can elicit apoptosis in neuronal cell lines, such as PC12, as well as in cortical neurons in primary culture. In a recent study we examined the relationship between the neurotoxic activity and SEC receptor-binding capacity of Aβ peptide using a technique originally described by Behl et al. [16] to generate neuronal cell lines that were resistant to the neurotoxic effect of Aβ peptide. PC12
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and specific in cell type or was a general resistance to cell death that could be elicited in diverse cell types. The results show that the resistance is specific to compounds that have apoptotic effects through the generation of hydroxyl radical or H # O # , including aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) , Aβ-(1-40), Aβ-(1-42), Aβ-(1-43), amylin, 6-hydroxydopamine and H # O # itself. The resistant subclones of PC12 were not resistant to other forms of apoptotic cell death or to necrotic cell death. The resistant state was also identified in a human hepatoma cell line, HepG2, when it was grown in the presence of aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) for several passages, indicating that the mechanism(s) or molecule(s) responsible for this resistance are not restricted to neuronal cells and may be relevant to the pathobiology of oxidative injury in other cell types. cells were grown in the presence of aggregated Aβ-(25-35) for several passages until resistant subclones grew out. Resistance to the toxic effect of Aβ peptide could not be explained by SEC receptor expression or activity because, even in the resistant subclone, the SEC receptor did not recognize the aggregated, cytotoxic form of Aβ peptide [22] . In this study, we examined whether the resistance was specific to aggregated peptides, specific to an apoptotic form of cell death or specific in cell type or was a general resistance to many forms of cell death in diverse cell types.
EXPERIMENTAL Materials
Aβ peptides 25-35, 1-40, 1-42 and 1-43 were synthesized by the solid-phase method, purified and subjected to amino acid composition and sequence analysis as previously described [23] . These peptides were prepared in an aggregated form by aging in water at 4 mM at 37 mC for 5 days. In previous studies [22] , these conditions resulted in predominantly aggregated peptide as determined by sedimentation analysis, spectrophotometric analysis of turbidity, light microscopy, CD as well as SDS\PAGE analysis. Human amylin was purchased from Bachem California (Torrance, CA, U.S.A.). Dopamine, -dopa, 6-hydroxydopamine, etoposide, colchicine, valinomycin, beauvericin, A23187, EGTA, ionomycin, cycloheximide, actinomycin D, transforming growth factor β, aurintricarboxylic acid (ATA), H # O # , catalase, superoxide dismutase (SOD), glutathione peroxidase, vitamin E and desipramine were purchased from Sigma Chemicals (St. Louis, MO, U.S.A.).
Cell lines
PC12 cells were kindly provided by Dr. Eugene Johnson and Dr. Karen O'Malley (Washington University, St. Louis, MO, U.S.A.) and were grown in RPMI medium (Gibco-BRL, Grand Island, NY, U.S.A.), containing 10 % heat-inactivated fetal calf serum and 5 % horse serum. Maintenance of HepG2 cells has been previously described [24] . U937 cells were purchased from ATCC and grown in RPMI medium with 10 % heat-inactivated fetal calf serum.
Assay of cytotoxicity
To assess the toxic effects of peptides and other agents in PC12, HepG2 and U937 cells, we used the MTT reduction assay [25, 26] . In this assay, a tetrazolium salt, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), is used as a colorimetric substrate for measuring cell viability. When cells are injured there is an alteration in cellular redox activity such that cells are unable to reduce the dye. Alterations in cellular redox activity, as measured by the MTT assay, correlate well with other measures of cytotoxicity in response to Aβ peptide [25] as well as in other types of toxicity [26] . For our MTT assay, PC12 cells were plated at density of 2i10%\ml in 24-well tissue culture plates and incubated with peptide in RPMI supplemented with 10 % horse serum and 5 % fetal calf serum. Unless otherwise indicated, this incubation was 24 h in duration. At the end of this time interval, MTT was added to a final concentration of 0n5 mg\ml. The incubation was continued for 2 h. Cell lysis buffer (20 % SDS, 50 % N,Ndimethylformamide, pH 4n7) was added (100 µl\well) and the incubation continued for another 2 h. Colorimetric analysis at 570 nM was then completed. Values in the presence of vehicle alone were considered to be 100 % control response, and values after cell lysis in PBS\0n5 % Triton X-100 were considered to be 0 % control response. This means that cytotoxicity is indicated by a reduction from 100 for the per cent control response. Results are reported as the meanp1 S.D. for four measurements at each point.
Assays of DNA fragmentation
Cells were lysed in 5 mM Tris\HCl buffer, pH 7n4, containing 0n5 % Triton X-100 and 20 mM EDTA for 20 min at 4 mC as described previously [27] . After centrifugation at 27 000 g for 15 min, supernatants were extracted with phenol\chloroform and precipitated in ethanol. Samples were subjected to electrophoresis on 1n2 % agarose gels. The gels were incubated with RNase A (20 µg\ml) at 37 mC for 3 h before staining with ethidium bromide.
RESULTS

Specificity of resistant state in the Aβ-resistant subclone of the PC12 cell line (PC12R)
In our previous studies we found that a subclone (PC12R) was resistant to the toxic effect of aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) and human amylin peptide, a peptide that is unrelated to Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) in primary sequence but forms fibrillar aggregates similar to those of aggregated Aβ [22] . To determine whether the PC12R subclone was only resistant to aggregated peptides or had a general resistance to apoptosis, we examined the effect of several other compounds known to have apoptotic effects by other mechanisms ( Figure 1 ). In each case the PC12R subclone was compared with the parent cell line by the MTT assay after being incubated for 24 h with the putative toxin. The results show the known toxic effect of aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) and amylin in the parent. The PC12R subclone was completely resistant to the toxic effect of aggregated Aβ-(25-35) and amylin. Interestingly, the PC12R subclone was also completely resistant to the toxic effect of 6- hydroxydopamine. 6-Hydroxydopamine was active as shown by its potent toxic effect in the parent PC12 cells. The effect of 6-hydroxydopamine was specific in that dopamine and -dopa did not have a toxic effect in the parent PC12 or PC12R subclone. We also examined the effect of the calcium ionophore ionomycin and the potassium ionophore beauvericin, which are known to induce apoptosis through increases in cytoplasmic Ca# + levels [28, 29] . In each case the ionophore had a similar potent toxic effect in the parent and PC12R subclone. These results suggest that the resistance was not specific to aggregated peptides and was not a general resistance to apoptosis. Next, we examined the effect of antimycin A [30] , an inhibitor of the cytochrome oxidase system which is thought to be toxic to neurons by a necrotic mechanism (Table 1) . Antimycin A was indeed toxic to PC12 cells, but there was an equivalent toxic effect in the parent PC12 and PC12R subclone.
Several other compounds with known neurotoxic effects were examined in the same protocol (Table 2 ). There was no difference between parent and PC12R subclone in the toxic effect of serum starvation, which is known to have a potent apoptotic effect. The calcium ionophore A23187 also had a potent toxic effect on both parent and subclone. Cycloheximide, actinomycin D, colchicine, EGTA and valinomycin all had equivalent toxic effects on the parent and subclone. Etoposide, an inhibitor of topoisomerase II [31] , had a weak toxic effect on both but transforming growth factor β was not toxic in either parent or subclone. These results provided further evidence that the resistant state of the PC12R subclone was not specific for aggregated peptides, was not a general resistance to apoptosis and did not appear to involve a resistance to the necrotic form of cell death. The susceptibility of the PC12R subclone to numerous toxins is similar to that of the parent PC12 cell line, indicating that a specific alteration in phenotype is responsible for resistance to Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . This specific phenotype probably involves a mechanism that is common to Aβ-(25-35) and 6-hydroxydopamine.
Pharmacological characteristics of the toxic effects of 6-hydroxydopamine as compared with aggregated Aβ-(25-35)
Next we compared the pharmacological characteristics of toxicity mediated by 6-hydroxydopamine with those of aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (Figure 2 ). The effect of 6-hydroxydopamine is first evident at 10-20 µM and reaches a plateau at about 40 µM We used Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) in these experiments because our previous studies [22] and studies from several other laboratories [13] [14] [15] [16] [17] [18] [19] [20] [21] have shown that the toxic effect of Aβ-(25-35) is identical with that of Aβ-(1-40) and Aβ-(1-42). Taken together, these studies have provided evidence that the sequence of Aβ-(25-35) represents the minimal sequence requirement for the toxic effect of any of the longer naturally occurring peptides. However, in order to exclude the possibility that the mechanism of the effect of the shorter peptide is different from that of the longer peptides, we also examined aggregated Aβ-(1-40), Aβ-(1-42) and Aβ- in the PC12 parent and resistant subclone using the MTT assay (Figure 2, bottom) . These peptides had a definite toxic effect in the parent PC12 cell line but had no effect on the resistant subclone. The concentrations of these longer peptides required for toxicity in the parent cell line were very similar to those of the shorter Aβ-(25-35) peptide.
The toxic effect of 6-hydroxydopamine presumably requires specific uptake by the target cell. To address this issue we compared the effect of the monoamine uptake inhibitor desipramine on the toxic effect of 6-hydroxydopamine and Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) in parental PC12 cells ( Figure 3A) . The results show that desipramine completely inhibits the toxic effect of 6-hydroxydopamine but does not inhibit the toxic effect of Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) even at concentrations that are 10-fold higher. The effect of desipramine is highly specific, as shown by comparing it with the inhibiting effect of ATA, which has been shown to inhibit endonucleases associated with apoptosis [32, 33] . Co-incubation of parental PC12 cells with ATA inhibited the toxic effect of 6-hydroxydopamine and Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) .
We also examined the possibility that scavengers of active oxygen intermediates would inhibit the toxic effects of 6-hydroxydopamine and Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . Several previous studies have shown that 6-hydroxydopamine and Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) [16] elicit the release of active oxygen intermediates during cellular toxicity. As shown in Figure 3 (B), we found that catalase and vitamin E markedly inhibit the toxic effect of both 6-hydroxydopamine and Aβ-(25-35) on parental PC12 cells. The inhibitory effect of catalase was not as great for Aβ-(25-35)-induced toxicity, but it was a significant effect and the specificity of the effect was demonstrated by the lack of any effect for superoxide dismutase. Taken together, these results suggest that the apoptotic effects of Aβ-(25-35) and 6-hydroxydopamine somehow involve active oxygen intermediates, particularly H # O # and hydroxyl radical. Moreover, the results raise the possibility that it is these intermediates that are toxic to the parental cells and that the resistant subclone is resistant to the toxic effect of H # O # and\or hydroxyl radical. To examine this possibility, we first determined the effect of H # O # on parental PC12 cells and the PC12R subclone using the MTT assay (Figure 4 ). The results show that H # O # is indeed toxic to parental PC12 cells, beginning at 10 nM and reaching a plateau between 60 and 100 nM. At these concentrations H # O # is not toxic to the PC12R subclone, providing evidence that the resistance to Aβ-(25-35), amylin and 6-hydroxydopamine involves a common resistance to the active oxygen intermediates generated by the effects of these substances. Higher concentrations of H # O # , greater than 500 nM, did elicit toxic effects in the PC12R subclone (results not shown), presumably by overwhelming the antioxidant mechanism.
Figure 6 Effect of (A) desipramine on DNA fragmentation in PC12 cells induced by Aβ-(25-35) and 6-hydroxydopamine, (B) catalase on DNA fragmentation in PC12 cells induced by 6-hydroxydopamine and (C) ATA on DNA fragmentation in PC12 cells induced by Aβ-(25-35) and 6-hydroxydopamine
Characteristics of the toxic effects of 6-hydroxydopamine and aggregated Aβ peptide as determined by DNA-fragmentation assay
Here we examined the possibility that the DNA-fragmentation assay could be used to confirm the results of our experiments with 6-hydroxydopamine and Aβ peptide using the MTT assay. First, we examined the effect of aggregated Aβ-(25-35) on parental PC12 cells using the DNA-fragmentation assay ( Figure  5A ). The results show that Aβ-(25-35) induced DNA fragmentation to a similar extent to serum starvation. The effect was time-dependent, first becoming evident between 24 and 48 h and increasing between 48 and 72 h. Secondly, we examined the effect of co-incubating parental PC12 cells with aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) and catalase ( Figure 5B ) or with aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) and vitamin E ( Figure 5C ). The results show that catalase and vitamin E inhibit the DNA-fragmenting effect of Aβ-(25-35) in a concentration-dependent fashion. The concentrations of catalase and vitamin E required to inhibit the DNA-fragmenting effect of Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) are identical with those that inhibit the toxic effect of Aβ-(25-35) in MTT assays. There was no evidence for DNA fragmentation by catalase alone ( Figure 5B) or vitamin E alone (results not shown). We also examined the effect of Aβ-(1-42) on the parent PC12 cell line using the DNA-fragmentation assay ( Figure 5D ). This peptide also had a DNA-fragmenting effect. The effect of Aβ-(1-42) on DNA fragmentation was not inhibited by SOD but it was inhibited by catalase and vitamin E.
Finally, we examined the effect of 6-hydroxydopamine on parental PC12 cells using the DNA-fragmentation assay ( Figure  6 ). The results show that 6-hydroxydopamine induces DNA fragmentation identically with that of Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . The DNAfragmenting effect of 6-hydroxydopamine is completely inhibited by desipramine, whereas the DNA-fragmenting effect of Aβ-(25-35) is not inhibited by desipramine ( Figure 6A ). There was no DNA fragmentation with the desipramine alone. DNA fragmentation in response to 6-hydroxydopamine was also markedly inhibited by catalase ( Figure 6B ). The effective inhibitory concentrations of catalase were similar for 6-hydroxydopamine and aggregated Aβ-(25-35) ( Figure 6B ). The DNA fragmentation induced by 6-hydroxydopamine was inhibited by ATA in a manner identical with that for Aβ-(25-35) ( Figure 6C ). These data provide confirmation, using two entirely different assay systems, that aggregated peptides and 6-hydroxydopamine induce apoptosis of PC12 cells by a common mechanism involving the action of active oxygen intermediates.
Differentiation of parental PC12 cells and the PC12R subclone induced by nerve growth factor (NGF)
The parent PC12 cells and the PC12R subclone were incubated with NGF for 7 days. In each case the cells underwent differentiation as evidenced by a marked increase in cell size and the development of neurite outgrowth. The cells were then incubated for 24 h with aggregated Aβ-(25-35) to assess its cytotoxicity by MTT assay (Figure 7) . The results show that Aβ-(25-35) has a significant toxic effect on NGF-differentiated parental PC12 cells. In fact, the toxic effect of Aβ-(25-35) is evident at lower concentrations in the NGF-differentiated PC12 cells than in undifferentiated PC12 cells (Figure 2 bottom) . However, Aβ-(25-35) is completely inactive as a toxin on the NGF-differentiated PC12R subclone. These data provide evidence that the mechanism of resistance is unaffected by differentiation and militate against the possibility that the resistant state is merely a characteristic of a particular differentiated state of a subpopulation of PC12.
Cell-type specificity of resistance to the toxic effect of aggregated Aβ peptide
To determine whether resistance was a specific property of neuronal cells or could be elicited in diverse cell types, we selected two other cell lines for further studies. The human hepatoma cell line HepG2 and the human lymphohistiocytic cell line U937 were incubated with aggregated Aβ-(25-35) for 10 passages in exactly the same manner as PC12 cells had been treated. The surviving subclones were passed once in medium without Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) and then subjected to the MTT assay after exposure to aggregated toxic Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (Figure 8 ).The results show that aggregated Aβ-(25-35) is toxic to HepG2 cells and that resistance to the toxic effect of Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) can be engendered in HepG2 cells in the same way that it is established in PC12 cells. In contrast, U937 cells are intrinsically resistant to the toxic effect of aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . Taken together these data indicate that the resistant state is not restricted to cells of neuronal origin and may be an intrinsic property of cells of leucocytic origin.
DISCUSSION
Several previous studies have shown that a subclone of PC12 cells which is resistant to the toxic effect of aggregated Aβ peptide can be identified after several passages in tissue culture in which the toxin is present and most of the parent cells die [16, 22] . In this study we examined the specificity of this resistant state. The results show that the Aβ-resistant subclone of PC12 cells is resistant to apoptosis induced by aggregated peptides, 6-hydroxydopamine and H # O # but not to other compounds that induce apoptosis by alternative mechanisms or to at least one compound that induces cell death by a necrotic mechanism. The resistant state could be elicited in another cell line, the human hepatoma cell line HepG2, and was an intrinsic property of still another cell line,the human lymphohistiocytic cell line U937. These data indicate that induction of the resistant state is not restricted to a single cell line and is not restricted to cells of neuronal origin.
Although a previous study had indicated that Aβ peptide induced a necrotic form of cell death [38] , our results indicate that apoptosis is involved. The effect of Aβ peptide is accompanied by DNA fragmentation which is very similar to that induced by 6-hydroxydopamine and serum starvation, and is inhibited by the endonuclease inhibitor ATA to an extent almost identical with that of 6-hydroxydopamine and serum starvation. Previous work from other laboratories, including studies of Aβ peptide in primary cultures of cortical neurons [39] and of 6-hydroxydopamine in PC12 cells [34] , have indicated that the injury is more consistent with an apoptotic rather than a necrotic form of cell death.
A number of lines of evidence indicate that resistance to the apoptotic effect of active oxygen intermediates explains the resistance of the PC12R subclone and the HepG2R subclone to Aβ peptide. First, studies with a number of compounds that have apoptotic and necrotic effects showed that resistance was specific for compounds known to induce cellular expression of active oxygen intermediates, the aggregated peptides Aβ and amylin as well as 6-hydroxydopamine. The PC12R subclone was not resistant to the toxic effect of antimycin A, calcium ionophores, potassium ionophores, cycloheximide, actinomycin D, colchicine, etoposide and serum starvation. Secondly, the apoptotic effects of aggregated Aβ peptide and 6-hydroxydopamine on parental PC12 cells were specifically inhibited by the antioxidants catalase and vitamin E, indicating that H # O # and possibly hydroxyl radicals were integrally involved in the toxic effect. Thirdly, the PC12R subclone was relatively resistant to the direct toxic effect of H # O # . Studies in which the parental PC12 cells and the PC12R subclone are differentiated by the action of NGF showed that the resistant state is not merely a function of a subclone in a particular differentiated state. Taken together with studies of HepG2 cells, the results show that the resistant state can also be elicited in several different cell types. It was interesting to observe that cells of leucocytic origin, as exemplified by the U937 cell line, were inherently resistant to the toxic effect of aggregated Aβ peptide and 6-hydroxydopamine. We do not know of another cell type that is resistant to aggregated Aβ peptide ( [22] ; D. H. Perlmutter, unpublished work). Although there are many possible explanations, the resistance of leucocytes to aggregated Aβ peptide presumably reflects the intrinsic antioxidant properties that permit these cells to survive and function as they release endogenous active oxygen intermediates.
There are at least two possible explanations for how the resistant subclones evolve during passage of the PC12 and HepG2 cell lines in tissue culture fluid supplemented with aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . On the one hand, specific genes may be activated or repressed in response to aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) , ultimately leading to the emergence of a resistant subclone. On the other hand, a subpopulation of PC12 and HepG2 cells, which is intrinsically resistant to the apoptotic effect of aggregated Aβ- (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) , may be selected by growth in the toxin. On the basis of data reported in this and previous studies, it is not yet possible to distinguish which of these two possibilities applies. The data reported here do show that the resistant subclones only differ from the parent cell lines in a very specific form of cell death and do not represent distinguishable differentiated states. In either case, the identification and characterization of the resistant subclones, compared with the parent cell lines, will provide important information about the biochemistry of cell death associated with aggregated Aβ peptide.
There are several possible mechanisms for resistance to the apoptotic effect of Aβ peptide in the subclones of the PC12 and HepG2 cell lines. The most obvious would be an increase in the expression or activity of endogenous antioxidants such as catalase and glutathione peroxidase. In fact, Sagara et al. [40] have presented evidence for increases in catalase and glutathione peroxidase in resistance subclones of PC12 cells. However, there was not a clear correlation between the level of increase in antioxidants and the degree of resistance. Moreover, previous studies have shown that there are substantial increases in catalase and glutathione peroxidase in PC12 cells differentiated with NGF [41] . We found that PC12 cells are just as susceptible to the toxic effects of Aβ peptide after differentiation with NGF. If anything, the NGF-differentiated PC12 cells undergo apoptosis at lower concentrations of Aβ-(25-35) than undifferentiated PC12 cells. Walkinshaw and Waters [34] found no differences in the apoptotic effect of 6-hydroxydopamine in undifferentiated as compared with NGF-differentiated PC12 cells. Taken together, these data suggest that increases in catalase and glutathione peroxidase cannot by themselves fully account for the resistant state. A second possible explanation for the resistant state could involve a decrease in nitric oxide production. Recent studies have shown that the combination of nitric oxide and H # O # has a particularly potent cytotoxic effect in several cell types [42, 43] . This possibility is less likely because specific inhibitors of nitric oxide synthase did not alter the effect of Aβ peptide on neurons in primary culture [16] . Thirdly, a change in trace metal composition, such as iron depletion or selenium depletion, could significantly alter resistance of PC12 cells and HepG2 cells to oxidative injury. Fourthly, it is possible that there is an increase in Bcl-2 or other anti-apoptotic gene products within the PC12 subclone. Several recent studies have shown that Bcl-2 overexpression protects cells from oxidative injury [44, 45] . However, in this case one might have expected the PC12R and HG2R subclones to be resistant to a broader range of apoptotic effectors. Fifthly, there could be a decrease in expression of the p75 neurotrophin receptor or in ERAB, proteins that have recently been implicated in mediating the toxicity of Aβ peptide [46, 47] , in the PC12R and HG2R subclones. It is, of course, possible that a combination of these alterations explains the resistant state. In any case, further studies of the mechanism for this resistant state will be relevant to understanding the pathobiology of neurodegenerative diseases associated with oxidative injury, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. It may also result in greater understanding of the pathobiology of oxidative injury in other tissues.
